Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
In: Cancer Investigation, Jg. 39 (2021), Heft 1, S. 9-14
academicJournal
Zugriff:
The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control. [ABSTRACT FROM AUTHOR]
Titel: |
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
|
---|---|
Autor/in / Beteiligte Person: | Pala, Laura ; Conforti, Fabio ; Cocorocchio, Emilia ; Ferrucci, Pierfrancesco ; De Pas, Martino Tommaso ; Stucchi, Sara ; Repetto, Matteo ; Saponara, Maristella ; Queirolo, Paola |
Zeitschrift: | Cancer Investigation, Jg. 39 (2021), Heft 1, S. 9-14 |
Veröffentlichung: | 2021 |
Medientyp: | academicJournal |
ISSN: | 0735-7907 (print) |
DOI: | 10.1080/07357907.2020.1844893 |
Schlagwort: |
|
Sonstiges: |
|